APrf Hamish Philpott
School of Medicine
College of Health
Eligible to supervise Masters and PhD (as Co-Supervisor) - email supervisor to discuss availability.
Dr Hamish Philpott is a gastroenterologist and early career researcher who has completed a PhD at Monash University related to eosinophilic esophagitis. Dr Philpott received a NHMRC scholarship to support his PhD studies, and since became the Philip Bushell Foundation Research Travel Award recipient for 2016/17, and has additional research funding from the philanthropic organisation for eosinophilic disease (ausEE). He has >40 research publications, most of which relate to eosinophilic gastrointestinal disease. Dr Philpott returned from the University of North Carolina Chapel Hill in June 2017, and has taken up a staff specialist position in Adelaide (Northern Adelaide Local Health Network/University of Adelaide).
| Date | Institution name | Country | Title |
|---|---|---|---|
| Monash University, Melbourne | Australia | PhD | |
| University of Adelaide | Australia | MBBS |
| Year | Citation |
|---|---|
| 2025 | Young, E., Wan, N., Philpott, H., & Singh, R. (2025). The West Catching Up With the East: High-Magnification NBI Is Accurate for the Diagnosis of Gastric Neoplasia in a Western Population. Journal of Gastroenterology and Hepatology Australia, 40(5), 1128-1134. WoS1 Europe PMC1 |
| 2025 | Philpott, H., Lemberg, D. A., Day, A. S., Rosenbaum, J., Singh, H., Rumore, S., . . . Sharma, A. (2025). Characteristics and management of eosinophilic esophagitis in Australasian children: a decade of experience. Internal Medicine Journal, 55(2), 284-289. |
| 2025 | Dellon, E. S., Collins, M. H., Bredenoord, A. J., Philpott, H., Biedermann, L., Dulcine, M., . . . Hirano, I. (2025). Etrasimod as a treatment for eosinophilic oesophagitis (VOYAGE): a double-blind, placebo-controlled, randomised, phase 2 trial. Lancet Gastroenterology and Hepatology, 10(7), 622-633. Scopus4 Europe PMC4 |
| 2025 | Taylor, S., Barwick, E., Perananthan, V., Parkash, N., Lucas, S., Chauhan, A., . . . Garg, M. (2025). Research Communication: Real-World Effectiveness of Budesonide Orodispersible Tablets for Eosinophilic Oesophagitis: The Importance of Patience and Education. Alimentary Pharmacology and Therapeutics, 62(2), 204-207. Scopus1 WoS1 Europe PMC1 |
| 2025 | Young, E., Philpott, H., & Singh, R. (2025). Texture and Colour Enhancement Imaging versus White Light Endoscopy for Detection of Dysplasia within Barrett's Oesophagus: A Pilot Study. Digestion, 9 pages. |
| 2023 | Au, M., Heddle, G., Young, E., Ryan, E., Graf, S., Tee, D., & Philpott, H. (2023). Anti-tumour necrosis factor-induced skin rashes in inflammatory bowel disease: a systematic review and evidence-based management algorithm. Internal Medicine Journal, 53(10), 1854-1865. Scopus8 WoS9 Europe PMC5 |
| 2023 | Thakk, K. P., Philpott, H., Lafata, S., Fowler, M., Keene, S., Iuga, A., & Dellon, E. S. (2023). Effect of Proton Pump Inhibitor Treatment in “PPI Non-responsivePatients with Eosinophilic Esophagitis. Journal of Gastrointestinal and Liver Diseases, 32(1), 15-22. Scopus8 WoS7 Europe PMC9 |
| 2023 | Kazaan, P., Seow, W., Tan, Z., Logan, H., Philpott, H., Huynh, D., . . . Edmund, T. (2023). Deliberate foreign body ingestion in patients with underlying mental illness: a retrospective multicentre study.. Australasian Psychiatry, 31(5), 619-624. Scopus7 WoS9 Europe PMC9 |
| 2022 | Dellon, E. S., Gonsalves, N., Abonia, J. P., Alexander, J. A., Arva, N. C., Atkins, D., . . . Aceves, S. S. (2022). International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature. Clinical Gastroenterology and Hepatology, 20(11), 2474-2484.e3. Scopus143 WoS115 Europe PMC106 |
| 2022 | Young, E., & Philpott, H. (2022). Pathophysiology of Dysphagia in Eosinophilic Esophagitis: Causes, Consequences, and Management. Digestive Diseases and Sciences, 67(4), 1101-1115. Scopus13 WoS15 Europe PMC13 |
| 2022 | Au, M., Rajagopalan, A., Tee, D., & Philpott, H. (2022). Immune checkpoint inhibitor colitis with concurrent cytomegalovirus reactivation. Internal Medicine Journal, 52(3), 504-505. Scopus1 WoS1 Europe PMC1 |
| 2022 | Young, E., Rojas Vasquez, L. S., Philpott, H., & Lim, A. (2022). Low FODMAP diet for treatment of irritable bowel syndrome. Cochrane Database of Systematic Reviews, 2022(8). Scopus1 |
| 2022 | Young, E. J., Rajandran, A., Philpott, H. L., Sathananthan, D., Hoile, S. F., & Singh, R. (2022). Mucosal imaging in colon polyps: New advances and what the future may hold. World Journal of Gastroenterology, 28(47), 6632-6661. Scopus6 WoS4 Europe PMC3 |
| 2021 | Philpott, H., & Dellon, E. S. (2021). Eosinophilic GI Disorders After Transplantation Are a Unique Transient Entity. American Journal of Gastroenterology, 116(7), 1554-1555. Scopus2 Europe PMC1 |
| 2021 | Young, E., Philpott, H., & Singh, R. (2021). Endoscopic diagnosis and treatment of gastric dysplasia and early cancer: Current evidence and what the future may hold. World Journal of Gastroenterology, 27(31), 5126-5151. Scopus55 WoS59 Europe PMC50 |
| 2021 | Sharma, A., Eluri, S., Philpott, H., Lemberg, D. A., & Dellon, E. S. (2021). EoE Down Under Is Still EoE: Variability in Provider Practice Patterns in Australia and New Zealand Among Pediatric Gastroenterologists. Digestive Diseases and Sciences, 66(7), 2301-2310. Scopus5 WoS5 Europe PMC6 |
| 2020 | Chan, A., Philpott, H., Lim, A. H., Au, M., Tee, D., Harding, D., . . . Singh, R. (2020). Anticoagulation and antiplatelet management in gastrointestinal endoscopy: A review of current evidence. WORLD JOURNAL OF GASTROINTESTINAL ENDOSCOPY, 12(11), 43 pages. WoS1 |
| 2020 | Sharma, A., & Philpott, H. (2020). Recognising eosinophilic oesophagitis. Frontline Gastroenterology, 11(1), 3-4. Scopus1 |
| 2020 | Philpott, H., Lee, S. Z., Arrington, A., McGee, S., & Dellon, E. S. (2020). Impact of food challenge on local oesophageal immunophenotype in eosinophilic oesophagitis.. Clinical Mechanisms in Allergic Disease, 50(4), 463-470. Scopus4 WoS4 Europe PMC2 |
| 2019 | Rumore, S., & Philpott, H. (2019). More than just reflux the era of eosinophilic oesophagitis. Medicine Today, 20(5), 49-52. |
| 2019 | Philpott, H., Dougherty, M., Torpy, D., & Dellon, E. (2019). Letter: reassuringly normal response to ACTH in children treated with swallowed topical corticosteroids for eosinophilic oesophagitis – authors’ reply. Alimentary Pharmacology and Therapeutics, 49(12), 1539. |
| 2018 | Philpott, H., & Dellon, E. (2018). The role of maintenance therapy in eosinophilic esophagitis: who, why, and how?. Journal of Gastroenterology, 53(2), 165-171. Scopus38 WoS32 Europe PMC30 |
| 2018 | Philpott, H., Dougherty, M. K., Reed, C. C., Caldwell, M., Kirk, D., Torpy, D. J., & Dellon, E. S. (2018). Systematic review: adrenal insufficiency secondary to swallowed topical corticosteroids in eosinophilic oesophagitis. Alimentary Pharmacology and Therapeutics, 47(8), 1071-1078. Scopus61 WoS53 Europe PMC49 |
| 2018 | Ellison, S., & Philpott, H. (2018). A New Paradigm in the Treatment of Eosinophilic Esophagitis: Proton Pump Inhibitors Are Safe, Aim for "Deep Remission". Journal of Pediatric Gastroenterology and Nutrition, 67(2), 146-147. |
| 2018 | Sharma, A., & Philpott, H. (2018). Food Bolus Impaction in the Era of Increased EoE Recognition: Push and Pull, Biopsy and Dilate Before It Is Too Late. Digestive Diseases and Sciences, 63(6), 1371-1373. Scopus3 WoS3 Europe PMC1 |
| 2018 | Philpott, H., & Dellon, E. (2018). Histologic improvement after 6 weeks of dietary elimination for eosinophilic esophagitis may be insufficient to determine efficacy.. Asia Pacific allergy, 8(2), e20. WoS22 Europe PMC20 |
| 2018 | Shahzad, M. A., Harding, D., Ruszkiewicz, A., Tran, E., England, G., & Philpott, H. (2018). Gastrointestinal: Olmesartan-induced enteropathy. Journal of Gastroenterology and Hepatology Australia, 33(10), 1691. Scopus4 WoS6 Europe PMC6 |
| 2018 | Philpott, H., Dougherty, M. K., & Dellon, E. S. (2018). Letter: screening for adrenal suppression in paediatric inflammatory bowel disease – authors’ reply. Alimentary Pharmacology and Therapeutics, 48(8), 885-886. |
| 2018 | Dellon, E. S., Liacouras, C. A., Molina-Infante, J., Furuta, G. T., Spergel, J. M., Zevit, N., . . . Bredenoord, A. J. (2018). Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference. Gastroenterology, 155(4), 1022-1033.e10. Scopus962 WoS864 Europe PMC715 |
| 2017 | Philpott, H., Garg, M., Tomic, D., Balasubramanian, S., & Sweis, R. (2017). Dysphagia: Thinking outside the box. World Journal of Gastroenterology, 23(38), 6942-6951. Scopus31 Europe PMC19 |
| 2017 | Tuck, C. J., Yao, C. K., Philpott, H. L., & Barrett, J. S. (2017). Questioning the Utility of Breath Testing in Clinical Practice. American Journal of Gastroenterology, 112(12), 1886. Scopus1 Europe PMC1 |
| 2017 | Philpott, H., & Thien, F. (2017). The Role of Allergy Testing in Eosinophilic Esophagitis: an Update of the Evidence.. Current treatment options in gastroenterology, 15(1), 26-34. Europe PMC5 |
| 2017 | Philpott, H., Kweh, B., & Thien, F. (2017). Eosinophilic esophagitis: Current understanding and evolving concepts. Asia Pacific Allergy, 7(1), 3-9. Scopus7 Europe PMC7 |
| 2017 | Philpott, H., & Dellon, E. S. (2017). A Penetrating Look at Eosinophilic Esophagitis Pathogenesis: Direct Antigen Exposure in the Esophagus?. Gastroenterology, 153(2), 605-606. Scopus3 Europe PMC3 |
| 2017 | Philpott, H., & Sweis, R. (2017). Hiatus Hernia as a Cause of Dysphagia. Current Gastroenterology Reports, 19(8), 40. Scopus17 Europe PMC12 |
| 2017 | Yao, C. K., Tuck, C. J., Barrett, J. S., Canale, K. E. K., Philpott, H. L., & Gibson, P. R. (2017). Poor reproducibility of breath hydrogen testing: Implications for its application in functional bowel disorders. United European Gastroenterology Journal, 5(2), 284-292. Scopus48 |
| 2016 | Philpott, H., Yu, S., & Rao, S. (2016). It's All in the Mix: Diagnosis and Management of Food Intolerance. Clinical Gastroenterology and Hepatology, 14(8), 1221-1222. Scopus2 Europe PMC3 |
| 2016 | Philpott, H., & Gibson, P. R. (2016). Letter: dietary therapy in eosinophilic oesophagitis – do not test, just eliminate and reintroduce the most common food triggers. Authors' reply. Alimentary Pharmacology and Therapeutics, 44(8), 905-906. Scopus1 Europe PMC1 |
| 2016 | Philpott, H., & Gibson, P. R. (2016). Letter: avoiding misconceptions about elimination diet for eosinophilic oesophagitis – authors’ reply. Alimentary Pharmacology and Therapeutics, 44(1), 100-101. |
| 2016 | Philpott, H., Nandurkar, S., Royce, S., Thien, F., & Gibson, P. (2016). Allergy tests do not predict food triggers in adult patients with eosinophilic oesophagitis. A comprehensive prospective study using five modalities. Alimentary Pharmacology and Therapeutics, 44(3), 223-233. Scopus103 Europe PMC78 |
| 2016 | Philpott, H., & Gibson, P. R. (2016). Editorial: Management of eosinophilic oesophagitis - Efficacy vs. effectiveness. Authors' reply. Alimentary Pharmacology and Therapeutics, 44(2), 199-200. |
| 2016 | Philpott, H., Nandurkar, S., Royce, S., Thien, F., & Gibson, P. (2016). A prospective open clinical trial of a proton pump inhibitor, elimination diet and/or budesonide for eosinophilic oesophagitis. Alimentary Pharmacology and Therapeutics, 43(9), 985-993. Scopus70 Europe PMC66 |
| 2016 | Philpott, H., Nandurkar, S., Royce, S. G., & Gibson, P. R. (2016). Ultrathin unsedated transnasal gastroscopy in monitoring eosinophilic esophagitis. Journal of Gastroenterology and Hepatology Australia, 31(3), 590-594. Scopus34 Europe PMC27 |
| 2016 | Peters, S. L., Yao, C. K., Philpott, H., Yelland, G. W., Muir, J. G., & Gibson, P. R. (2016). Editorial: gut-directed hypnotherapy or low FODMAP diet for the treatment of irritable bowel syndrome? Authors' reply. Alimentary Pharmacology and Therapeutics, 44(8), 902-903. |
| 2016 | Peters, S. L., Yao, C. K., Philpott, H., Yelland, G. W., Muir, J. G., & Gibson, P. R. (2016). Randomised clinical trial: the efficacy of gut-directed hypnotherapy is similar to that of the low FODMAP diet for the treatment of irritable bowel syndrome. Alimentary Pharmacology and Therapeutics, 44(5), 447-459. Scopus135 Europe PMC99 |
| 2015 | Yao, C. K., Barrett, J. S., Philpott, H., Chung, A. R. T., van Langenberg, D., Garg, M., & Gibson, P. R. (2015). Poor predictive value of breath hydrogen response for probiotic effects in IBS. Journal of Gastroenterology and Hepatology Australia, 30(12), 1731-1739. Scopus11 Europe PMC11 |
| 2015 | Philpott, H., Nandurkar, S., Lubel, J., & Gibson, P. R. (2015). Food, fibre, bile acids and the pelvic floor: An integrated low risk low cost approach to managing irritable bowel syndRome. World Journal of Gastroenterology, 21(40), 11379-11386. Scopus6 Europe PMC3 |
| 2015 | Philpott, H., Nandurkar, S., Royce, S. G., & Gibson, P. R. (2015). Letter: Seasonality in eosinophilic oesophagitis and food bolus obstruction - What about recurrent episodes?. Alimentary Pharmacology and Therapeutics, 42(7), 936. Scopus2 Europe PMC2 |
| 2015 | Philpott, H., Nandurkar, S., Thien, F., Bloom, S., Lin, E., Goldberg, R., . . . Gibson, P. (2015). Seasonal recurrence of food bolus obstruction in eosinophilic esophagitis. Internal Medicine Journal, 45(9), 939-943. Scopus35 Europe PMC28 |
| 2015 | Philpott, H., Lubel, J., & Nandurkar, S. (2015). Letter: Colestyramine for chronic unexplained diarrhoea - Promising but much to learn?. Alimentary Pharmacology and Therapeutics, 42(3), 388. Scopus1 Europe PMC1 |
| 2015 | Philpott, H., Royce, S., Thien, F., Nandurkar, S., & Gibson, P. (2015). What gastroenterologists should know about testing patients with eosinophilic esophagitis for food allergies. Clinical Gastroenterology and Hepatology, 13(5), 1029-1030. Europe PMC1 |
| 2015 | Philpott, H., Royce, S., Nandurkar, S., Thien, F., & Gibson, P. (2015). IgG and EoE: Too soon for a paradigm shift away from IgE. Gastroenterology, 148(2), 453-454. Scopus6 Europe PMC6 |
| 2015 | Philpott, H., Nandurkar, S., Thien, F., Gibson, P., & Royce, S. (2015). Eosinophilic esophagitis: A clinicopathological review. Pharmacology and Therapeutics, 146, 12-22. Scopus4 |
| 2015 | Philpott, H., Nandurkar, S., Thien, F., Gibson, P., & Royce, S. (2015). Eosinophilic esophagitis: A clinicopathological review. Pharmacology and Therapeutics, 146, 12-22. Scopus18 Europe PMC13 |
| 2014 | Philpott, H. L., Nandurkar, S., Lubel, J., & Gibson, P. R. (2014). Drug-induced gastrointestinal disorders. Postgraduate Medical Journal, 90(1065), 411-419. Scopus28 Europe PMC21 |
| 2014 | Philpott, H., Nandurkar, S., Royce, S. G., Thien, F., & Gibson, P. R. (2014). Risk factors for eosinophilic esophagitis. Clinical and Experimental Allergy, 44(8), 1012-1019. Scopus22 Europe PMC18 |
| 2013 | Chandran, S., Testro, A., Urquhart, P., La Nauze, R., Ong, S., Shelton, E., . . . Froomes, P. (2013). Risk stratification of upper GI bleeding with an esophageal capsule. Gastrointestinal Endoscopy, 77(6), 891-898. Scopus23 Europe PMC11 |
| 2013 | Sinclair, M., Roberts, S., Kemp, W., Knight, V., Dev, A., Gow, P., . . . Nicoll, A. (2013). Epidemiology of hepatitis B-associated hepatocellular carcinoma in Victoria. Internal Medicine Journal, 43(5), 501-506. Scopus7 Europe PMC4 |
| 2013 | Philpott, H., Gibson, P. R., Thien, F., & Nandurkar, S. (2013). Letter: An allergic phenotype in patients with eosinophilic oesophagitis and asthma. Alimentary Pharmacology and Therapeutics, 37(7), 755-756. Scopus1 Europe PMC1 |
| 2013 | Philpott, H., Nandurkar, S., Lubel, J., & Gibson, P. R. (2013). Alternative investigations for irritable bowel syndrome. Journal of Gastroenterology and Hepatology (Australia), 28(1), 73-77. Scopus13 Europe PMC8 |
| 2012 | Philpott, H., Gow, P., Crowley, P., Nandurkar, S., Douglass, J., & Gibson, P. R. (2012). Systemic mastocytosis: a gastroenterological perspective.. Frontline gastroenterology, 3(1), 5-9. Europe PMC6 |
| 2009 | Shakib, S., Philpot, H., & Clark, R. (2009). What we have here is a failure to communicate! Improving communication between tertiary to primary care for chronic heart failure patients. Internal Medicine Journal, 39(9), 595-599. Scopus12 WoS10 Europe PMC10 |
| 2008 | Philpott, H., Kette, F., Hissaria, P., Gillis, D., & Smith, W. (2008). Chronic urticaria: the autoimmune paradigm. Internal Medicine Journal, 38(11), 852-857. Scopus15 WoS13 Europe PMC10 |
| 2008 | Philpott, H., Hissaria, P., Warren, L., Singhal, N., Brown, M., Proudman, S., . . . Gillis, D. (2008). Eosinophilic fasciitis as a paraneoplastic phenomenon associated with metastatic colorectal carcinoma. Australasian Journal of Dermatology, 49(1), 27-29. Scopus20 WoS16 Europe PMC10 |
| 2008 | Fock, K., Talley, N., Fass, R., Goh, K., Katelaris, P., Hunt, R., . . . Manatsathit, S. (2008). Asia-Pacific consensus on the management of gastroesophageal reflux disease: Update. Journal of Gastroenterology and Hepatology, 23(1), 8-22. Scopus159 WoS137 Europe PMC120 |
| 2007 | Philpott, H. L. (2007). A failure to relax. Australian Family Physician, 36(10), 849-850. |
| 2005 | Hay, P., Loukas, A., & Philpott, H. (2005). Prevalence and characteristics of men with eating disorders in primary care: how do they compare to women and what features may aid in identification?. Primary Care & Community Psychiatry, 10(1), 1-6. Scopus20 WoS17 |
| Year | Citation |
|---|---|
| 2018 | Lee, Z. S., Tee, D., & Philpott, H. (2018). Can tissue or serum eosinophilia predict severity of Crohn's disease?. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 33 (pp. 108-109). WILEY. |
| 2018 | Philpott, H., & Dellon, E. S. (2018). Patients with eosinophilic esophagitis have a distinct immunophenotype that is detectable with food challenge, indicating esophageal food antigen presentation. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 33 (pp. 134). WILEY. |
| 2018 | Philpott, H., & Singh, R. (2018). Endocytoscopy as an alternative to tissue biopsy to detect eosinophilic esophagitis: A novel and promising technique?. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 33 (pp. 9-10). WILEY. |
| 2018 | Philpott, H., & Dellon, E. S. (2018). CD 138 expression is increased in active eosinophilic esophagitis and not gastroesophageal reflux disease, and normalizes with treatment: Time for a new biomarker?. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 33 (pp. 133-134). WILEY. |
| 2018 | Philpott, H., & Dellon, E. S. (2018). Decreased CXCR3 expression in gastroesophageal reflux but not eosinophilic esophagitis may provide mechanistic insight. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 33 (pp. 132-133). WILEY. |
| 2018 | Shahzad, M. A., Harding, D., Ruszkiewicz, A., Tran, E., England, G., & Philpott, H. (2018). Olmesartan-induced enteropathy: An uncommon adverse effect of a commonly prescribed drug. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 33 (pp. 173-174). WILEY. |
| 2017 | Philpott, H., & Dellon, E. S. (2017). Solid Organ Transplantation is not a Risk Factor for Eosinophilic Oesophagitis: A Review of 13,792 Transplants Performed on a Predominantly Adult Population in North Carolina. In AMERICAN JOURNAL OF GASTROENTEROLOGY Vol. 112 (pp. S193). Orlando, FL: NATURE PUBLISHING GROUP. |
| 2017 | Philpott, H., & Dellon, E. S. (2017). Six Weeks May Be Insufficient to Determine the Success of Elimination Diet Based on Histological Parameters Alone in Adults With Eosinophilic Esophagitis. In AMERICAN JOURNAL OF GASTROENTEROLOGY Vol. 112 (pp. S193). Orlando, FL: NATURE PUBLISHING GROUP. |
| 2017 | Philpott, H., Beitia, R., Barnes, C., Arrington, A., Perjar, I., Hollyfield, J., . . . Dellon, E. S. (2017). Decline in Esophageal Eosinophil Counts can be Substantial in Many Patients With Eosinophilic Esophagitis After Treatment With Proton Pump Inhibitors. In AMERICAN JOURNAL OF GASTROENTEROLOGY Vol. 112 (pp. S194). Orlando, FL: NATURE PUBLISHING GROUP. DOI |
| 2017 | Philpott, H., Reed, C. C., Dougherty, M., & Dellon, E. S. (2017). Adrenal Insufficiency Is Rare With Topical Corticosteroid Treatment for Eosinophilic Esophagitis: A Systematic Review. In AMERICAN JOURNAL OF GASTROENTEROLOGY Vol. 112 (pp. S193-S194). Orlando, FL: NATURE PUBLISHING GROUP. |
| Year | Citation |
|---|---|
| 2020 | Kaazan, P., Seow, W., Tan, Z., Bednarz, J., Chung, A., Cock, C., . . . Tse, E. (2020). Deliberate foreign body swallowing in patients with underlying mental illness: A retrospective multicenter observational study. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. |
| 2020 | Au, M., Chan, A., Smart, C., & Philpott, H. (2020). Ustekinumab in the management of anti-tumor necrosis factor-induced psoriasiform lesions in inflammatory bowel disease: A systematic review. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. |
| 2020 | Chan, A., Tee, D., Rajagopalan, A., Chinnaratha, A., & Philpott, H. (2020). Targeted use of videocapsule endoscopy: Can we reduce the numbers based on symptoms or patient demographics?. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. |
| 2020 | Chan, A., Singh, R., Ruszkiewicz, A., & Philpott, H. (2020). Eosinophilic muscularis propria of the esophagus: The cause of achalasia?. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. |
| 2020 | Au, M., Rajagopalan, A., Tee, D., & Philpott, H. (2020). A case of checkpoint inhibitor-induced colitis with concurrent cytomegalovirus reactivation: Good response to combined antiviral and immunosuppressive therapy with infliximab. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. |
| 2019 | Philpott, H., & Dellon, E. (2019). Assessment of syndecan-1 as a novel serum biomarker for monitoring eosinophilic esophagitis. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. |
| 2019 | Lipschitz, B., Mccomish, J., & Philpott, H. (2019). Increased frequency of human leukocyte antigen DQ2 and related haplotypes in a large prospectively enrolled cohort of pediatric patients with eosinophilic esophagitis. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. |
| 2019 | Huynh, T., Apostolov, R., Mitchell, H., O'Connor, J., Low, E., Niewiadomski, O., . . . Garg, M. (2019). The costs and outcomes of eosinophilic esophagitis in Australia: Data from a metropolitan hospital. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. |
| 2019 | Chandran, V., & Philpott, H. (2019). Significant divergence in the management of esophageal reflux in Australia: Prescription of proton pump inhibitors, ordering of pH studies, and frequency of fundoplication vary markedly across the country. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. |
| 2019 | Philpott, H., Hebbard, G., Garas, G., Tutticci, N., Prince, D., & Lidums, I. (2019). The number of adult gastroenterology and hepatology trainees in Australia varies between states and should be changed to meet workforce distribution constraints. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. |
| 2019 | Philpott, H., Sharma, A., Rosenbaum, J., Singh, H., Rumore, S., Ellison, S., . . . Lemberg, D. (2019). Rapid increase in the prevalence of eosinophilic esophagitis among Australasian children: A decade of experience from six capital cities. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. WoS1 |
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2022 | Co-Supervisor | Advances in the endoscopic diagnosis and treatment of gastrointestinal neoplasia | Doctor of Philosophy | Doctorate | Part Time | Mr Edward John Young |
| 2022 | Co-Supervisor | Advances in the endoscopic diagnosis and treatment of gastrointestinal neoplasia | Doctor of Philosophy | Doctorate | Full Time | Mr Edward John Young |
Connect With Me
External Profiles
